VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.73M | 3.37M | 3.59M | 4.42M | 3.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.85M | 7.97M | 8.58M | 9.10M | 7.37M |
| Operating Income | -6.85M | -7.97M | -8.58M | -9.10M | -7.37M |
| Income Before Tax | -10.69M | -11.69M | -10.87M | -9.59M | -7.28M |
| Income Tax Expenses | -240.70K | -240.70K | -240.70K | -- | -- |
| Earnings from Continuing Operations | -10.45 | -11.45 | -10.63 | -9.59 | -7.28 |
| Earnings from Discontinued Operations | 333.20K | -2.20K | -263.70K | -989.90K | -2.30M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.11M | -11.45M | -10.89M | -10.58M | -9.58M |
| EBIT | -6.85M | -7.97M | -8.58M | -9.10M | -7.37M |
| EBITDA | -6.84M | -7.96M | -8.57M | -9.09M | -7.37M |
| EPS Basic | -2.25 | -2.52 | -2.44 | -2.43 | -2.29 |
| Normalized Basic EPS | -1.24 | -1.45 | -1.36 | -1.37 | -1.08 |
| EPS Diluted | -2.25 | -2.52 | -2.44 | -2.43 | -2.29 |
| Normalized Diluted EPS | -1.24 | -1.45 | -1.36 | -1.37 | -1.08 |
| Average Basic Shares Outstanding | 19.29M | 18.20M | 17.90M | 17.49M | 16.70M |
| Average Diluted Shares Outstanding | 19.29M | 18.20M | 17.90M | 17.49M | 16.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
